Politico January 5, 2024
Lauren Gardner, David Lim, Megan R. Wilson, Megan Messerly

Pollsters and political operatives said the fact Americans are unlikely to see their drug prices go down by November means the FDA’s decision is unlikely to have any tangible effect on the presidential election.

The FDA’s decision to allow states to import prescription drugs from Canada may not help President Joe Biden’s reelection campaign — or Americans’ pocketbooks.

That’s because Florida’s drug importation plan, which the Food and Drug Administration greenlit on Friday, has a long way to go before Americans end up saving money on their prescriptions, if they ever do.

Pharma companies and the Canadian government — longtime opponents of bulk drug importation — are unlikely to sanction the flow of prescription drugs over the border. Canada has...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article